Trending News Today: Affordable Care Act Bronze Plans at Risk

A Virginia insurer announced they will stop selling bronze plans in the Obamacare marketplace next year. According to Kaiser Health News, this could cause other insurers to consider dropping this level of coverage as well. A spokeswoman from the company said it will continue to sell bronze plans in other health exchanges.

The FDA approved Probuphine, a device implanted into the arms of people facing addictions to heroin and painkillers. The device delivers buprenorphine for a period of 6 months and can prevent relapses that would occur if a patient missed a dose of medication, The New York Times reported. It is estimated that 325,000 patients who are taking buprenorphine meet the criterion to receive the implant.

After significant scrutiny for a lack of transparency regarding executive compensation, Blue Shield of California said their CEO made $3.5 million last year. Kaiser Health News states that this is a 40% increase since his start in 2013. The company released the compensation (including base salary and incentive awards) for its 10 highest paid executives.